Hints and tips:
Related Special Reports
...s competition watchdog announced plans this month for an in-depth probe into the veterinary market and whether the “roll-up” of thousands of small clinics may have forced up the price of treatments and drugs...
...DeepMind is also using AI to explore other areas of biology and accelerate research into drug discovery and delivery, material science, mathematics, weather prediction and nuclear fusion technology....
...Leqembi, priced at $26,500 a year, was the first drug with a black-box warning — the most severe designation about possible side effects — to be granted full approval by the US Food and Drug Administration...
...Several start-ups specialising in AI for drug discovery have had to abandon drugs after studies showed they were not as effective as hoped....
...The drug is not yet approved in the US or Europe....
...Drugs of the GLP-1 group suppress appetite with remarkable effectiveness. Weight loss success stories have resonated in Wall Street and the C-suite....
...Development costs are estimated at $2.3bn per drug by Deloitte, leaving return on R&D investment at a pitiful 1.2 per cent. AI should improve matters by speeding up drug discovery....
...It is the first drug found to slow the progression of the disease, rather than just treat the symptoms....
...Ellen ‘t Hoen, of research group Medicines Law & Policy, said there had been progress on areas such as access to antiviral drugs and vaccines, a severe problem during the pandemic, but said the current text...
...The pioneering UK Biobank is to publish the largest-ever release of genetic sequencing data to boost the research and development of drugs to treat diseases ranging from heart conditions to cancers....
...Ergomed has two businesses: running early-stage drug trials and “pharmacovigilance” or drug safety. Multi-year contracts and sticky revenues, especially in the latter division, appeal to investors....
...In the UK, Eisai submitted the drug for approval in May....
...DeepMind, and others, are also using AI to create new materials, discover new drugs, solve mathematical conjectures, forecast the weather more accurately and improve the efficiency of experimental nuclear...
...It has a thin pipeline of drugs under development and an earnings structure that is heavily dependent on royalty income from HIV drugs....
...The company can then allocate more towards developing its own exclusive drugs as well as so-called biosimilar treatments....
...Drug Administration....
...The US Food and Drug Administration in January approved lecanemab, a drug co-developed by Japanese drugmaker Eisai and US biotech Biogen, under an accelerated process....
...In a letter to the judge, Bankman-Fried’s lawyers hinted that their client might testify, but raised concern that he was not receiving doses of Adderall, a drug used to treat attention-deficit hyperactivity...
...Its investors lent about £130mn to the utility’s holding company Kemble Water Finance Ltd in 2018 and 2020....
...Tuna Trading Ltd. with a very respectable 44.5 and 42 points each....
...Nvidia’s AI-friendly graphics processing units are massively in demand, or “considerably harder to get than drugs”, as Tesla boss Elon Musk puts it....
...— Honeydog Ltd (29.9 per cent stake): Honeydog is . . ....
...During the trial, witnesses described how the victim — who denied in court that he was a member of a local drug gang — had been struck with weapons including an axe and kicked and punched by a group of men...
...Big pharma companies distribute medicines and products on a global scale but develop fewer drugs themselves, meaning they invest heavily in biotech to secure their drug pipeline....
...The UK government is trying to placate the disgruntled life sciences industry by investing in mining health data and increasing the domestic manufacturing of vaccines and drugs....
International Edition